A randomized phase III trial investigating platinum and taxane chemotherapy in metastatic castration resistant prostate cancer (mCRPC) patients with alterations in DNA damage response (DDR) genes (OPTION-DDR) CCTG-PR-25 NCT06439225. Journal Articles uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Kolinsky, Michael Paul
  • Chi, Kim N
  • Hotte, Sebastien
  • Brundage, Michael Donald
  • Ong, Michael
  • Boren, David
  • Reaume, M Neil
  • Wyatt, Alexander William
  • Parulekar, Wendy R
  • Ding, Keyue
  • Jafri, Mariam

publication date

  • June 2025